-
AP/Taiwan Ministry of National DefenseChina launched major military drills around Taiwan on Tuesday, simulating attacks and maritime blockades, in what Beijing called a warning after Taiwan's president labeled China a hostile foreign force. -
Cristian Hernandez/APA federal judge on Monday paused plans by the Trump administration to end temporary legal protections for hundreds of thousands of Venezuelans, a week before they were scheduled to expire.
-
The case was brought by a chapter of Catholic Charities in Wisconsin, which says that it should be able to opt out of the mandatory state unemployment compensation system. -
The staff of the Institute of Museum and Library Services was placed on administrative leave Monday morning, following a meeting between IMLS leadership and DOGE staff. -
SpaceX launched four people into space Monday evening on a first-ever human mission to orbit Earth's polar regions. If successful, the mission also will be the first to cultivate mushrooms as a crop. -
Last week, the White House said the National Security Council, the White House counsel office and President Trump adviser Elon Musk were all looking into the mishap. But now, that probe has wrapped -
The 22nd Amendment bans a person from being elected U.S. president more than twice. But some legal experts point to plausible strategies that President Trump could try to serve a third term. -
New court filings give more details about a small number of DOGE staffers granted sweeping access to sensitive government data systems. -
The annual influx of charity-seekers to Pakistan's biggest city has gained increased government attention this year as Pakistan steps up efforts to curb begging. -
Dr. Jean Kaseya is now figuring out how to cope with the new foreign aid landscape. -
President Trump says he isn't ruling out the possibility of seeking a 3rd term in office. And, an executive order targets the Smithsonian Institution to restore "sanity to American history." -
Health care price transparency is one of the few bipartisan issues in Washington, D.C. But much of the information is not helpful to patients, and there's no evidence that it's lowering costs.
